デジタル糖尿病管理の世界市場規模調査＆予測、タイプ別、製品別、地域別分析、2023-2030年

デジタル糖尿病管理とは、モバイルアプリ、ウェアラブルデバイス、その他のデジタルツールなどのデジタル技術を使用して、糖尿病患者の状態を監視、管理、改善することを指します。

糖尿病は、インスリンの分泌不足またはインスリンを効果的に使用できないことによる高血糖を特徴とする慢性代謝疾患です。デジタル糖尿病管理ソリューションは、血糖値、投薬、身体活動、食事を追跡・分析するためのツールやリソースを提供することで、糖尿病患者がセルフケアに積極的に参加できるようにすることを目的としています。市場成長を促進する主な要因は、糖尿病有病率の上昇、糖尿病管理のためのクラウドベースの企業ソリューションの採用拡大、糖尿病ケア機器における人工知能の出現、糖尿病管理のためのデジタルプラットフォームの普及とモバイルアプリの採用の増加であり、これらは予測期間中の市場成長をサポートすると予想されます。

さらに、糖尿病の世界の有病率は、主に座りがちなライフスタイル、不健康な食生活、高齢化によって着実に増加しています。糖尿病患者数が増加の一途をたどる中、効率的で拡張性の高い糖尿病管理ソリューションへのニーズが高まっています。例えば、国際糖尿病連合（IDF）によると、2019年には20～79歳の成人が4億6,300万人近く糖尿病を患っています。また、2045年には約7億人に達すると予測されています。その結果、糖尿病の有病率の増加が市場の成長をサポートすると予想されます。さらに、糖尿病に関連する医療支出の増加とe-ヘルスの採用の増加は、予測期間中に市場に有利な機会を創出すると予測されます。しかし、新興経済諸国での低採用とデータセキュリティが、2023-2030年の予測期間を通じて市場成長を阻害します。

デジタル糖尿病管理の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、糖尿病有病率の上昇、認知度と患者エンゲージメントの向上、ヘルスケアとインフラの成長、遠隔患者モニタリングへの注目の高まり、および支援的な償還政策により、2022年の市場を独占しました。一方、アジア太平洋地域は、eヘルス導入の増加、糖尿病有病率の増加、ヘルスケア意識の高まり、医療費の増加、遠隔医療と遠隔モニタリングの導入の増加などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のデジタル糖尿病管理市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 デジタル糖尿病管理の世界市場力学

• デジタル糖尿病管理市場の影響分析（2020-2030年）
  • 市場促進要因
    • 糖尿病有病率の上昇
    • 糖尿病管理のためのクラウドベースの企業向けソリューションの採用拡大
    • 糖尿病治療機器における人工知能の登場
  • 市場の課題
    • 新興経済における採用率の低さとデータセキュリティ
  • 市場機会
    • 糖尿病関連の医療費の増加
    • eヘルス導入の増加

第4章 世界のデジタル糖尿病管理市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 デジタル糖尿病管理の世界市場：タイプ別

• 市場スナップショット
• デジタル糖尿病管理の世界市場：タイプ別、実績 - ポテンシャル分析
• デジタル糖尿病管理の世界市場：タイプ別推定・予測 2020-2030年
• デジタル糖尿病管理市場、サブセグメント別分析
  • ハンドヘルドデバイス
  • ウェアラブルデバイス

第6章 デジタル糖尿病管理の世界市場：製品別

• 市場スナップショット
• デジタル糖尿病管理の世界市場：製品別、実績 - ポテンシャル分析
• デジタル糖尿病管理の世界市場：製品別推定・予測2020～2030年
• デジタル糖尿病管理市場、サブセグメント別分析
  • 持続血糖モニタリングシステム
  • スマートグルコースメーター
  • スマートインスリンポンプ
  • スマートインスリンペン
  • アプリ

第7章 デジタル糖尿病管理の世界市場、地域分析

• 主要国
• 主な新興国
• デジタル糖尿病管理市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別推定・予測、2020-2030年
    • 製品別の推定・予測、2020～2030年
  • カナダ
• 欧州デジタル糖尿病管理市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋デジタル糖尿病管理市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのデジタル糖尿病管理市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第8章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • F. Hoffmann-La Roche Ltd.
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Becton, Dickinson And Company
  • Bayer Ag
  • Acon Laboratories, Inc.
  • Medtronic Plc.
  • Novo Nordisk A/S
  • Terumo Corporation
  • Abbott Laboratories
  • Johnson And Johnson Limited
  • Dexcom, Inc

第9章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Digital Diabetes Management Market, report scope
• TABLE 2. Global Digital Diabetes Management Market estimates & forecasts by region 2020-2030 (USD Billion)
• TABLE 3. Global Digital Diabetes Management Market estimates & forecasts by Type 2020-2030 (USD Billion)
• TABLE 4. Global Digital Diabetes Management Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 5. Global Digital Diabetes Management Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 6. Global Digital Diabetes Management Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Digital Diabetes Management Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Digital Diabetes Management Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Digital Diabetes Management Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Digital Diabetes Management Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Digital Diabetes Management Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Digital Diabetes Management Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Digital Diabetes Management Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Digital Diabetes Management Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. U.S. Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 17. U.S. Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. Canada Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 19. Canada Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. UK Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 22. UK Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. Germany Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 25. Germany Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. France Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 28. France Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. Italy Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 31. Italy Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Spain Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 34. Spain Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. RoE Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 37. RoE Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. China Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 40. China Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. India Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 43. India Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. Japan Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 46. Japan Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. South Korea Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 49. South Korea Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. Australia Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 52. Australia Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. RoAPAC Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. Brazil Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 58. Brazil Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Mexico Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 61. Mexico Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. RoLA Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 64. RoLA Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. Saudi Arabia Digital Diabetes Management Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 67. South Africa Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. RoMEA Digital Diabetes Management Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Digital Diabetes Management Market
• TABLE 70. List of primary sources, used in the study of global Digital Diabetes Management Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Digital Diabetes Management Market, research methodology
• FIG 2. Global Digital Diabetes Management Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Digital Diabetes Management Market, key trends 2022
• FIG 5. Global Digital Diabetes Management Market, growth prospects 2023-2030
• FIG 6. Global Digital Diabetes Management Market, porters 5 force model
• FIG 7. Global Digital Diabetes Management Market, pest analysis
• FIG 8. Global Digital Diabetes Management Market, value chain analysis
• FIG 9. Global Digital Diabetes Management Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Digital Diabetes Management Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Digital Diabetes Management Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Digital Diabetes Management Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Digital Diabetes Management Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Digital Diabetes Management Market, regional snapshot 2020 & 2030
• FIG 15. North America Digital Diabetes Management Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Digital Diabetes Management Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Digital Diabetes Management Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Digital Diabetes Management Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Digital Diabetes Management Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Digital diabetes management refers to using digital technologies, such as mobile apps, wearable devices, and other digital tools, to help individuals with diabetes monitor, manage, and improve their condition. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to either inadequate insulin production or the body's inability to use insulin effectively. Digital diabetes management solutions aim to empower patients with diabetes to take an active role in their self-care by providing tools and resources to track and analyze their blood glucose levels, medication, physical activity, and diet. The key factors driving the market growth are the rising prevalence of diabetes, growing adoption of cloud-based enterprise solutions for diabetes management, the advent of artificial intelligence in diabetes care devices, and increasing penetration of digital platforms and adoption of mobile apps for diabetes management that anticipated to support the market growth during forecast period.

Moreover, the global prevalence of diabetes has been increasing steadily, primarily due to sedentary lifestyles, unhealthy diets, and an aging population. As the number of people with diabetes continues to rise, there is a growing need for efficient and scalable diabetes management solutions. For instance, as per the International Diabetic Federation (IDF), in 2019, there were nearly 463 million adults aged between 20-79 years were suffering from diabetes. Also, the amount is anticipated to reach around 700 million by 2045. As a result, the growing prevalence of diabetes is anticipated to support market growth. Additionally, increasing diabetes-related health expenditure and rising adoption of e-health are anticipated to create a lucrative opportunity for the market during the forecast period. However, the low adoption in developing economies and data security stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Digital Diabetes Management Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevalence of diabetes, increasing awareness and patient engagement, growing healthcare and infrastructure, increasing focus on remote patient monitoring, and supportive reimbursement policies. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the growing adoption of e-health, increasing prevalence of diabetes, rising healthcare awareness, increasing healthcare expenditure, and growing adoption of telemedicine and remote monitoring.

Major market player included in this report are:

• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson And Company
• Bayer Ag
• Acon Laboratories, Inc.
• Medtronic Plc
• Novo Nordisk A/S
• Terumo Corporation
• Abbott Laboratories
• Johnson And Johnson Limited
• Dexcom, Inc

Recent Developments in the Market:

• In September 2020, Roche Diagnostics (Switzerland) introduced a remote patient monitoring solution, that is an innovation of the RocheDiabetes Care Platform that utilises its pattern detection feature. These product launch helps to expand company product portfolio globally.

Global Digital Diabetes Management Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, Product, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Handheld Devices
• Wearable Devices

By Product:

• Continuous blood glucose monitoring systems
• Smart glucose meter
• Smart insulin pumps
• Smart insulin pens
• Apps

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Digital Diabetes Management Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Digital Diabetes Management Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3. Digital Diabetes Management Market, by Product, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Digital Diabetes Management Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Digital Diabetes Management Market Dynamics

• 3.1. Digital Diabetes Management Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of diabetes
    • 3.1.1.2. Growing adoption of cloud-based enterprise solutions for diabetes management
    • 3.1.1.3. Advent of artificial intelligence in diabetes care devices
  • 3.1.2. Market Challenges
    • 3.1.2.1. Low adoption in developing economies and data security
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing diabetes-related health expenditure
    • 3.1.3.2. Rising adoption of e-health

Chapter 4. Global Digital Diabetes Management Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Digital Diabetes Management Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Digital Diabetes Management Market by Type, Performance - Potential Analysis
• 5.3. Global Digital Diabetes Management Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4. Digital Diabetes Management Market, Sub Segment Analysis
  • 5.4.1. Handheld Devices
  • 5.4.2. Wearable Devices

Chapter 6. Global Digital Diabetes Management Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Digital Diabetes Management Market by Product, Performance - Potential Analysis
• 6.3. Global Digital Diabetes Management Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 6.4. Digital Diabetes Management Market, Sub Segment Analysis
  • 6.4.1. Continuous blood glucose monitoring systems
  • 6.4.2. Smart glucose meter
  • 6.4.3. Smart insulin pumps
  • 6.4.4. Smart insulin pens
  • 6.4.5. Apps

Chapter 7. Global Digital Diabetes Management Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Digital Diabetes Management Market, Regional Market Snapshot
• 7.4. North America Digital Diabetes Management Market
  • 7.4.1. U.S. Digital Diabetes Management Market
    • 7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Product breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Digital Diabetes Management Market
• 7.5. Europe Digital Diabetes Management Market Snapshot
  • 7.5.1. U.K. Digital Diabetes Management Market
  • 7.5.2. Germany Digital Diabetes Management Market
  • 7.5.3. France Digital Diabetes Management Market
  • 7.5.4. Spain Digital Diabetes Management Market
  • 7.5.5. Italy Digital Diabetes Management Market
  • 7.5.6. Rest of Europe Digital Diabetes Management Market
• 7.6. Asia-Pacific Digital Diabetes Management Market Snapshot
  • 7.6.1. China Digital Diabetes Management Market
  • 7.6.2. India Digital Diabetes Management Market
  • 7.6.3. Japan Digital Diabetes Management Market
  • 7.6.4. Australia Digital Diabetes Management Market
  • 7.6.5. South Korea Digital Diabetes Management Market
  • 7.6.6. Rest of Asia Pacific Digital Diabetes Management Market
• 7.7. Latin America Digital Diabetes Management Market Snapshot
  • 7.7.1. Brazil Digital Diabetes Management Market
  • 7.7.2. Mexico Digital Diabetes Management Market
• 7.8. Middle East & Africa Digital Diabetes Management Market
  • 7.8.1. Saudi Arabia Digital Diabetes Management Market
  • 7.8.2. South Africa Digital Diabetes Management Market
  • 7.8.3. Rest of Middle East & Africa Digital Diabetes Management Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. F. Hoffmann-La Roche Ltd.
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Becton, Dickinson And Company
  • 8.3.3. Bayer Ag
  • 8.3.4. Acon Laboratories, Inc.
  • 8.3.5. Medtronic Plc.
  • 8.3.6. Novo Nordisk A/S
  • 8.3.7. Terumo Corporation
  • 8.3.8. Abbott Laboratories
  • 8.3.9. Johnson And Johnson Limited
  • 8.3.10. Dexcom, Inc

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption